Pharmacological interaction between pancuronium bromide and anaesthetics.
D015065:17-Hydroxycorticosteroids / Q000494:pharmacology; D000731:Androstanes / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000765:Anesthesia, Conduction; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001965:Bromides; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D004569:Electroencephalography; D004594:Electrophysiology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006221:Halothane / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D009119:Muscle Contraction; D009132:Muscles / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009388:Neostigmine / Q000494:pharmacology; D010880:Piperidines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013261:Sterols / Q000494:pharmacology; D013874:Thiopental / Q000494:pharmacology*; D014630:Vagus Nerve / Q000502:physiology
D015065:17-Hydroxycorticosteroids; D000731:Androstanes; D001965:Bromides; D010880:Piperidines; D013261:Sterols; D009388:Neostigmine; D013874:Thiopental; D006221:Halothane